These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 16723096

  • 1. In vitro characteristics of poly(lactic-co-glycolic acid) microspheres incorporating gelatin particles loading basic fibroblast growth factor.
    Li SH, Cai SX, Liu B, Ma KW, Wang ZP, Li XK.
    Acta Pharmacol Sin; 2006 Jun; 27(6):754-9. PubMed ID: 16723096
    [Abstract] [Full Text] [Related]

  • 2. A novel biodegradable system based on gelatin nanoparticles and poly(lactic-co-glycolic acid) microspheres for protein and peptide drug delivery.
    Li JK, Wang N, Wu XS.
    J Pharm Sci; 1997 Aug; 86(8):891-5. PubMed ID: 9269865
    [Abstract] [Full Text] [Related]

  • 3. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres.
    Liu J, Meisner D, Kwong E, Wu XY, Johnston MR.
    Biomaterials; 2007 Jul; 28(21):3236-44. PubMed ID: 17434581
    [Abstract] [Full Text] [Related]

  • 4. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres.
    Perets A, Baruch Y, Weisbuch F, Shoshany G, Neufeld G, Cohen S.
    J Biomed Mater Res A; 2003 Jun 15; 65(4):489-97. PubMed ID: 12761840
    [Abstract] [Full Text] [Related]

  • 5. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
    He JT, Su HB, Li GP, Tao XM, Mo W, Song HY.
    Int J Pharm; 2006 Feb 17; 309(1-2):101-8. PubMed ID: 16413979
    [Abstract] [Full Text] [Related]

  • 6. A protein delivery system: biodegradable alginate-chitosan-poly(lactic-co-glycolic acid) composite microspheres.
    Zheng CH, Gao JQ, Zhang YP, Liang WQ.
    Biochem Biophys Res Commun; 2004 Oct 29; 323(4):1321-7. PubMed ID: 15451441
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel.
    Jeon O, Kang SW, Lim HW, Hyung Chung J, Kim BS.
    Biomaterials; 2006 Mar 29; 27(8):1598-607. PubMed ID: 16146647
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S, Shi Y, Li L, Xu J, Schaper A, Kissel T.
    Eur J Pharm Biopharm; 2008 Feb 29; 68(2):214-23. PubMed ID: 17651954
    [Abstract] [Full Text] [Related]

  • 11. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
    Zhang H, Lu Y, Zhang G, Gao S, Sun D, Zhong Y.
    Int J Pharm; 2008 Mar 03; 351(1-2):244-9. PubMed ID: 18024022
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Nokhodchi A.
    Colloids Surf B Biointerfaces; 2009 Nov 01; 74(1):340-9. PubMed ID: 19717287
    [Abstract] [Full Text] [Related]

  • 15. Preparation and characterization of PLGA microspheres containing a staphylokinase variant (K35R).
    He JT, Tao XM, Mo W, Song HY.
    Yao Xue Xue Bao; 2006 Jan 01; 41(1):12-8. PubMed ID: 16683521
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
    Díez S, Tros de Ilarduya C.
    Eur J Pharm Biopharm; 2006 Jun 01; 63(2):188-97. PubMed ID: 16697172
    [Abstract] [Full Text] [Related]

  • 18. Controlled release of bioactive doxorubicin from microspheres embedded within gelatin scaffolds.
    Defail AJ, Edington HD, Matthews S, Lee WC, Marra KG.
    J Biomed Mater Res A; 2006 Dec 15; 79(4):954-62. PubMed ID: 16941588
    [Abstract] [Full Text] [Related]

  • 19. Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone.
    Kim HK, Chung HJ, Park TG.
    J Control Release; 2006 May 15; 112(2):167-74. PubMed ID: 16542746
    [Abstract] [Full Text] [Related]

  • 20. Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor.
    Yoon JJ, Chung HJ, Lee HJ, Park TG.
    J Biomed Mater Res A; 2006 Dec 15; 79(4):934-42. PubMed ID: 16941589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.